Literature DB >> 9000316

The Stroop effect in schizophrenic patients.

H H Hepp1, S Maier, L Hermle, M Spitzer.   

Abstract

Schizophrenic patients (n = 44) and normal controls (n = 50) performed a computerized version of the Stroop color-word interference task. Schizophrenic patients generally showed more Stroop interference than normal subjects. The effect was neither related to demographic variables, nor to actual psychopathology. However, the course of the disorder was related to the Stroop effect, in that acute, chronic, and schizoaffective patients displayed a larger interference effect than patients with a recurrent episode. From a methodological perspective, the computerized version of the Stroop task proved to be more sensitive to interference effects in the patient group. The finding of enhanced reverse Stroop interference in patients strongly preoccupied with colors is discussed within the framework of MacLeod and Dunbar's (MacLeod and Dunbar, 1988) theory of Stroop interference involving differential practice effects.

Entities:  

Mesh:

Year:  1996        PMID: 9000316     DOI: 10.1016/s0920-9964(96)00080-1

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  16 in total

1.  A normative study on visual reaction times and two Stroop colour-word tests.

Authors:  R Barbarotto; M Laiacona; R Frosio; M Vecchio; A Farinato; E Capitani
Journal:  Ital J Neurol Sci       Date:  1998-06

2.  Failures in top-down control in schizophrenia revealed by patterns of saccadic eye movements.

Authors:  Sonia Bansal; Benjamin M Robinson; Carly J Leonard; Britta Hahn; Steven J Luck; James M Gold
Journal:  J Abnorm Psychol       Date:  2019-06-13

3.  Failure of schizophrenia patients to overcome salient distractors during working memory encoding.

Authors:  Britta Hahn; Benjamin M Robinson; Samuel T Kaiser; Alexander N Harvey; Valerie M Beck; Carly J Leonard; Emily S Kappenman; Steven J Luck; James M Gold
Journal:  Biol Psychiatry       Date:  2010-06-08       Impact factor: 13.382

4.  Frontal lobe alterations in schizophrenia: neuroimaging and neuropsychological findings.

Authors:  Juan Carlos Sanz de la Torre; Maite Barrios; Carme Junqué
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-11-22       Impact factor: 5.270

5.  Neuropsychological performance in patients with schizophrenia and controls as a function of cigarette smoking status.

Authors:  Victoria C Wing; Ingrid Bacher; Kristi A Sacco; Tony P George
Journal:  Psychiatry Res       Date:  2011-06-12       Impact factor: 3.222

6.  Influence of empathetic pain processing on cognition in schizophrenia.

Authors:  Kesong Hu; Marijn Lijffijt; Theodore P Beauchaine; Zhiwei Fan; Hui Shi; Shuchang He
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-12-05       Impact factor: 5.270

7.  Impaired Filtering and Hyperfocusing: Neural Evidence for Distinct Selective Attention Abnormalities in People with Schizophrenia.

Authors:  Britta Hahn; Benjamin M Robinson; John E Kiat; Joy Geng; Sonia Bansal; Steven J Luck; James M Gold
Journal:  Cereb Cortex       Date:  2022-04-20       Impact factor: 4.861

8.  Color Stroop and negative priming in schizophrenia: an fMRI study.

Authors:  Lida Ungar; Paul G Nestor; Margaret A Niznikiewicz; Cynthia G Wible; Marek Kubicki
Journal:  Psychiatry Res       Date:  2010-01-30       Impact factor: 3.222

9.  Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia.

Authors:  Taryn G Moss; Kristi A Sacco; Taryn M Allen; Andrea H Weinberger; Jennifer C Vessicchio; Tony P George
Journal:  Drug Alcohol Depend       Date:  2009-05-17       Impact factor: 4.492

10.  Executive attention in schizophrenic males and the impact of COMT Val108/158Met genotype on performance on the attention network test.

Authors:  Carolin Opgen-Rhein; Andres H Neuhaus; Carsten Urbanek; Eric Hahn; Thomas Sander; Michael Dettling
Journal:  Schizophr Bull       Date:  2008-01-16       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.